Solid pharmaceutical composition comprising lercanidipine

摘要

The present invention relates to a solid pharmaceutical composition comprising amorphous lercanidipine or an amorphous, pharmaceutically acceptable salt of lercanidipine as active ingredient. In order to provide a pharmaceutical composition, in which the amorphous form of the active ingredient is relatively stable, it is proposed that the composition contains a hydrogel-forming agent.